Skip to content
ClinCalc Pro
Menu
Uterotonic

Oxytocin

Brand names: Syntocinon

Oxytocin is a synthetic form of the posterior pituitary hormone used in obstetrics to induce or augment labour and to prevent or treat postpartum haemorrhage.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It binds uterine oxytocin receptors to increase the frequency and force of myometrial contractions, with receptor sensitivity rising towards term.

Prescribing in practice

  • Excessive dosing or infusion rate can cause uterine hyperstimulation with fetal distress or uterine rupture, so labour induction/augmentation must be titrated against contractions and continuous fetal monitoring.
  • Prolonged high-dose infusion with large volumes of electrolyte-free fluid can cause water intoxication and hyponatraemia owing to its antidiuretic effect.
  • Rapid intravenous bolus can cause hypotension, tachycardia, and arrhythmia, so it is given by slow injection or controlled infusion.

Monitoring

Monitor uterine activity and continuous fetal heart rate during labour, together with maternal blood pressure, pulse, and fluid balance.

Counselling the patient

  • Explain to the woman that this medicine strengthens contractions to help labour or to reduce bleeding after delivery.
  • The infusion is closely controlled and the baby's heart rate is monitored throughout.
  • Tell the team if contractions feel excessively strong or unrelenting.

Evidence & guidelines

A cornerstone of NICE-endorsed labour management and active management of the third stage of labour to reduce postpartum haemorrhage.

Reference: RCOG Induction of Labour Guideline; WHO PPH Prevention Guidelines; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.